Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-036484

Kiniksa Pharmaceuticals International, plc · KNSA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Stephen F. Mahoney
Officer — President & COO
Period of report
May 29, 2018
Accepted (ET)
May 29, 2018 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001730430

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common SharesMay 29, 2018C6,392$0.00A79,589D
Class A Common Sharesholding———36,598IBy Krisha S. Mahoney as trustee for the Stephen F. Mahoney 2016 Irrevocable Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series C Preferred SharesF2,F1—Feb 9, 2018P6,392A——Class A Common Shares6,3926,392D
Series A Preferred SharesF3—May 29, 2018C107,050D——Class B Common Shares107,0500D
Series C Preferred SharesF1—May 29, 2018C6,392D——Class A Common Shares6,3920D
Class B Common SharesF4—May 29, 2018C107,050A——Class A Common Shares107,050656,027D

Explanation of responses